Thomas J. Schuetz
CHIEF EXECUTIVE OFFICER at Compass Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Compass Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Compass Therapeutics Inc. June 10, 202684.5%
-
Compass Therapeutics Inc. June 15, 202379.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 8, 2026 | Compass Therapeutics Inc. | Shares withheld for tax | −36,687 | $6.52 | $239,199 |
| Jan 9, 2026 | Compass Therapeutics Inc. | Shares withheld for tax | −46,777 | $5.35 | $250,257 |
| Jan 2, 2026 | Compass Therapeutics Inc. | Grant or award | +250,000 | $5.17 | $1,292,500 |
| Nov 16, 2025 | Compass Therapeutics Inc. | Shares withheld for tax | −44,025 | $4.83 | $212,641 |
| May 27, 2025 | Compass Therapeutics Inc. | Open-market purchase | +10,000 | $2.11 | $21,100 |
| Feb 8, 2025 | Compass Therapeutics Inc. | Shares withheld for tax | −41,687 | $3.50 | $145,905 |
| Jan 9, 2025 | Compass Therapeutics Inc. | Shares withheld for tax | −58,054 | $1.86 | $107,980 |
| Feb 8, 2024 | Compass Therapeutics Inc. | Shares withheld for tax | −44,782 | $1.45 | $64,934 |
| Jan 9, 2024 | Compass Therapeutics Inc. | Grant or award | +637,500 | $1.93 | $1,230,375 |
| Nov 17, 2023 | Compass Therapeutics Inc. | Shares withheld for tax | −44,025 | $1.50 | $66,038 |
| Mar 10, 2023 | Compass Therapeutics Inc. | Open-market purchase | +10,000 | $3.37 | $33,700 |
| Feb 27, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $3.98 | $79,600 |
| Feb 15, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $3.86 | $77,200 |
| Feb 8, 2023 | Compass Therapeutics Inc. | Grant or award | +500,000 | — | — |
| Jan 31, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $4.05 | $81,000 |
Questions about Thomas J. Schuetz
What boards is Thomas J. Schuetz on?
Thomas J. Schuetz sits on the board of Compass Therapeutics Inc.
What company is Thomas J. Schuetz the CEO of?
Thomas J. Schuetz is CHIEF EXECUTIVE OFFICER of Compass Therapeutics Inc.
How long has Thomas J. Schuetz served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.